- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Pharma Pulse 7/31/24: Forgetting the Patient, Five Fast Facts About IVIG & more
The latest news for pharma industry insiders.
You Are Forgetting the Patient, but You’re Not Alone
Vincent Keunen, founder and CEO of Andaman7 shares his thoughts on how industry can achieve true patient centricity through emerging platforms and digital tools.
By functioning as an antibody replacement therapy, IVIG can be used to manage a wide range of inflammatory and autoimmune disorders.
Big Pharma Rallies and Moves Past Obesity
Rotation into laggard pharmaceutical stocks is being helped by optimism over regulations.
Advanced Clinical Announces Opening of New Office in India
Advanced Clinical announced the opening of a new office in Ahmedabad, India. This strategic expansion marks a significant milestone in its ongoing global expansion efforts and underscores a commitment to addressing the evolving needs of the company’s clients while becoming more competitive in the global market.
Miranda Schmalfuhs on LinkedIn
Check out the first part of my insightful talk with Charlotte Owens, MD, FACOG of Organon and keep your eyes on Pharmaceutical Executive for the other parts of our talk posting every morning this week!
Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
